Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,829-18,840 of 23,847
Drug study icon
CompletedNCT03618030

PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand how people respond to the medication PRC-063 in practice and what may need to be adjusted.

Multiple locations, including Bradenton
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Purdue Pharma, Canada
Condition
ADHD
Drug study icon
CompletedNCT03172481

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand how people respond to the medication PRC-063 in practice and what may need to be adjusted.

Multiple locations, including Newport Beach
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Purdue Pharma, Canada
Condition
ADHD
Drug study icon
CompletedNCT02139111

PRC-063 in Adolescent ADHD

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand whether the medication PRC-063 can give earlier or clearer feedback during care.

Multiple locations, including Los Angeles
ADHDDrugFrom 12 Years to 17 Years
Countries
United States, Canada
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Drug study icon
CompletedNCT02225639

PRC-063 in an ADULT Workplace Environment

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand whether the medication PRC-063 can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Newport Beach
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Behavioral study icon
CompletedNCT05528562

Pre-exposure Prophylaxis (PrEP) Rapid Access

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Boston Medical Center
Condition
Addiction
Drug study icon
WithdrawnNCT04021017

PRE-GAiN Bone Health Study

This summary needs review. Please check the official study record and contact the research team for details.

In Saskatoon
Eating disordersDrugFrom 12 Years to 19 Years
Countries
Canada
Sponsor
University of Saskatchewan
Condition
Eating disorders
Behavioral study icon
CompletedNCT06608550

Pre-procedure Short Movie Video Training on the Child's Fear, Anxiety and Satisfaction

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

In Mersin
AnxietyBehavioralFrom 9 Years to 12 Years
Countries
Türkiye
Sponsor
Tarsus University
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.